Machine learning classifiers for screening nonalcoholic fatty liver disease in general adults

被引:8
|
作者
Qin, Shenghua [1 ,2 ]
Hou, Xiaomin [1 ]
Wen, Yuan [1 ]
Wang, Chunqing [1 ]
Tan, Xiaxian [1 ]
Tian, Hao [1 ]
Ao, Qingqing [1 ]
Li, Jingze [1 ]
Chu, Shuyuan [3 ]
机构
[1] Guilin Peoples Hosp, Hlth Management Ctr, Guilin, Peoples R China
[2] Philippine Christian Univ, Manila, Philippines
[3] Guilin Med Univ, Lab Resp Dis, Affiliated Hosp, Guilin 541001, Guangxi, Peoples R China
关键词
D O I
10.1038/s41598-023-30750-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is one of major causes of end-stage liver disease in the coming decades, but it shows few symptoms until it develops into cirrhosis. We aim to develop classification models with machine learning to screen NAFLD patients among general adults. This study included 14,439 adults who took health examination. We developed classification models to classify subjects with or without NAFLD using decision tree, random forest (RF), extreme gradient boosting (XGBoost) and support vector machine (SVM). The classifier with SVM was showed the best performance with the highest accuracy (0.801), positive predictive value (PPV) (0.795), F1 score (0.795), Kappa score (0.508) and area under the precision-recall curve (AUPRC) (0.712), and the second top of area under receiver operating characteristic curve (AUROC) (0.850). The second-best classifier was RF model, which was showed the highest AUROC (0.852) and the second top of accuracy (0.789), PPV (0.782), F1 score (0.782), Kappa score (0.478) and AUPRC (0.708). In conclusion, the classifier with SVM is the best one to screen NAFLD in general population based on the results from physical examination and blood testing, followed by the classifier with RF. Those classifiers have a potential to screen NAFLD in general population for physician and primary care doctors, which could benefit to NAFLD patients from early diagnosis.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Nonalcoholic Fatty Liver Disease
    Wang, Xiao Jing
    Malhi, Harmeet
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (09) : ITC65 - ITC80
  • [42] Nonalcoholic Fatty Liver Disease
    Fitzgerald, Margaret A.
    NURSE PRACTITIONER, 2007, 32 (02): : 6 - 7
  • [43] Nonalcoholic fatty liver disease
    Elizabeth M. Brunt
    Vincent W.-S. Wong
    Valerio Nobili
    Christopher P. Day
    Silvia Sookoian
    Jacquelyn J. Maher
    Elisabetta Bugianesi
    Claude B. Sirlin
    Brent A. Neuschwander-Tetri
    Mary E. Rinella
    Nature Reviews Disease Primers, 1
  • [44] Nonalcoholic fatty liver disease
    Madan, P
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (07) : 734 - 735
  • [45] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [46] Nonalcoholic Fatty Liver Disease
    Filipovic, Branka
    Forbes, Alastair
    Tepes, Bojan
    Dumitrascu, Dan L.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018
  • [47] Nonalcoholic fatty liver disease
    Bebawi, Emmanuel
    Takla, Mark
    Leonard, Jennifer
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (26) : E909 - E909
  • [48] Nonalcoholic fatty liver disease
    Lemoine, Maud
    Serfaty, Lawrence
    PRESSE MEDICALE, 2012, 41 (02): : 169 - 189
  • [49] Nonalcoholic Fatty Liver Disease
    Worm, N.
    Stein, J.
    Strohle, A.
    DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (02): : 85 - 94
  • [50] Nonalcoholic Fatty Liver Disease
    Paredes, Angelo H.
    Torres, Dawn M.
    Harrison, Stephen A.
    CLINICS IN LIVER DISEASE, 2012, 16 (02) : 397 - +